Loring Fund for Lymphoma Research Pilot Grant Program

September 09, 2016

The mission of the Pilot Grant Program is to fund short-term, innovative, high-impact research with the greatest potential to rapidly advance our treatment of mature lymphoid malignancies in adults. This includes both low-grade and high-grade lymphomas as well as CLL. The highest priority will be given to applications addressing indolent or relapsed lymphoma.  Applications focusing on acute lymphoid leukemias (ALL, PLL), plasma cell dyscrasias, or myeloid malignancies are beyond the scope of this program and will not be accepted. Proposals may have a clinical, translational, or basic science focus.  

Award Amount: $150,000 for one year
Indirect Cost Rate: 15% (cap)
Scope: Clinical, Translational or Basic Science Investigation in Adult Lymphoma
Eligibility: HMS Faculty (Instructor or above) at DF/HCC member institutions (MGH, BWH, DFCI, BIDH)

Application Deadline: November 1, 2016

Additional Information:
Deb Zelen, Program Officer
Loring Fund for Lymphoma Research
MGH Cancer Center
dzelen@mgh.harvard.edu
617-726-9523